Page 19 - விருப்பங்கள் ஓய்வூதியங்கள் ஒன்றுபட்டது கிஂக்டம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from விருப்பங்கள் ஓய்வூதியங்கள் ஒன்றுபட்டது கிஂக்டம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In விருப்பங்கள் ஓய்வூதியங்கள் ஒன்றுபட்டது கிஂக்டம் Today - Breaking & Trending Today

These Stock Market Gauges Show Excessive Optimism

These Stock Market Gauges Show Excessive Optimism
forbes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forbes.com Daily Mail and Mail on Sunday newspapers.

Percent Index , Call Ratio , Stock Market Gauges , சதவீதம் குறியீட்டு , அழைப்பு ரேஶியோ ,

Tier One Silver Inc.: Tier One Silver Grants Stock Options


Tier One Silver Inc.: Tier One Silver Grants Stock Options
VANCOUVER, BC / ACCESSWIRE / April 12, 2021 /
Tier One Silver ( Tier One or the Company ) announces the grant of incentive stock options for the purchase of an aggregate of 7,715,000 common shares of the Company, 6.1% of the total shares issued and outstanding, to employees, officers, directors and consultants. The options are exercisable at C$1.00 per share, will vest over two years and expire five years from the date of grant.
A Message from Peter Dembicki, President, CEO & Director:
Over the past six months, Tier One Silver has expanded its premier exploration portfolio on the coast of Peru, obtained drill permits for its flagship Curibaya project and raised C$13.45 million for the Company. ....

Region De Tacna , British Columbia , Natasha Frakes , Kostenloser Wertpapierhandel , Peter Dembicki , Corporate Communications , Tier One Silver Inc , Tier One Silver , Tier One , One Silver , Coastal Batholith , பகுதி டி டக்னா , பிரிட்டிஷ் கொலம்பியா , நடாஷா ப்ரகேச் , பெருநிறுவன தகவல்தொடர்புகள் , அடுக்கு ஒன்று வெள்ளி இன்க் , அடுக்கு ஒன்று வெள்ளி , அடுக்கு ஒன்று , ஒன்று வெள்ளி ,

Vardhman Textiles allots 68,900 equity shares under ESOP

Passage Bio Receives European Commission Orphan Designation for PBKR03 for Treatment of Krabbe Disease


- Urgency for effective treatment underscored by European Commission designation for investigational gene therapy PBKR03
- Global Phase 1/2 trial – GALax-C – PBKR03 planned to initiate in first half of 2021
PHILADELPHIA, April 05, 2021 (GLOBE NEWSWIRE) Passage Bio, Inc. (Nasdaq: PASG), a clinical-stage genetic medicines company focused on developing transformative therapies for rare monogenic central nervous system (CNS) disorders, today announced that the European Commission has granted Orphan designation for PBKR03, an adeno-associated virus (AAV)-delivery gene therapy for the treatment of Krabbe disease (Globoid Cell Leukodystrophy). The designation was based on a positive opinion from the European Medicines Agency Committee for Orphan Medicinal Products. Currently, there are no approved disease-modifying therapies available for Krabbe disease, a rare lysosomal storage disease that most often presents early in a child’s life. The U.S. Food and Drug Administrat ....

University Of Pennsylvania , United States , Gwen Fisher , Stuart Henderson , Bruce Goldsmith , Exchange Commission , University Of Pennsylvania Gene Therapy Program , European Union , European Commission , Drug Administration , Passage Bio Inc , Globoid Cell Leukodystrophy , European Medicines Agency Committee , Orphan Medicinal , Fast Track , Orphan Drug , Rare Pediatric Disease , Passage Bio , Gene Therapy Program , Private Securities Litigation Reform Act , Risk Factors , Bio Investors , Bio Media , Inc Stock Exchange , Press Release , Designation Pasg ,